15-Deoxy-Δ12,14-prostaglandins D2 and J2 are potent activators of human eosinophils

Journal of Immunology

Volumn 168, Issue 7, 2002, Pages 3563-3569

  Monneret, Guillaume ^a   Li, Hongping ^a   Vasilescu, Julian ^a   Rokach, Joshua ^a   Powell, William S ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

15 DEOXY DELTA12,14 PROSTAGLANDIN D2; 15 DEOXY DELTA12,14 PROSTAGLANDIN J2; 5 OXO 6,8,11,14 ICOSATETRAENOIC ACID; ADENYLATE CYCLASE; ANTIINFLAMMATORY AGENT; CD11B ANTIGEN; ICOSANOID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROSTAGLANDIN D2 DERIVATIVE; PROSTAGLANDIN RECEPTOR; UNCLASSIFIED DRUG;

ACTIN POLYMERIZATION; ANTIGEN EXPRESSION; ARTICLE; CALCIUM MOBILIZATION; CONTROLLED STUDY; DRUG SELECTIVITY; ENZYME ACTIVITY; EOSINOPHIL; HUMAN; HUMAN CELL; MACROPHAGE; PRIORITY JOURNAL; TH2 CELL;

EID: 0036533485     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.168.7.3563     Document Type: Article

References (49)

1. 2 is a ligand for the adipocyte determination factor PPARγ
2. 2 metabolite binds peroxisome proliferator-activated receptor-γ and promotes adipocyte differentiation
3. PPARγ agonists: Therapeutic role in diabetes, inflammation and cancer
4. PPARγ agonists inhibit production of monocyte inflammatory, cytokines
5. The nuclear receptor PPARγ and immunoregulation: PPARγ mediates inhibition of helper T cell responses
6. The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation
7. Activation of proliferator-activated receptors-α and γ induces apoptosis of human monocyte-derived macrophages
8. Contribution of cyclopentenone prostaglandins to the resolution of inflammation through the potentiation of apoptosis in activated macrophages
9. 2 integrin-dependent oxidative burst: Involvement of a mechanism distinct from peroxisome proliferator-activated receptor-γ ligation
10. Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IκB kinase
11. 2 inhibits multiple steps in the NF-κB signaling pathway
12. 2 inhibition of NF-κB-DNA binding through covalent modification of the p50 subunit
13. Characterization of the recombinant human prostanoid DP receptor and identification of L-644,698, a novel selective DP agonist
14. 2 is a potent chemoattractant for human eosinophils that acts via a novel DP receptor
15. 2 selectively induces chemotaxis in T helper type 2 cells, eosinophils, and basophils via seven-transmembrane receptor CRTH2
16. Total synthesis of potent proinflammatory 5-oxo-ETE and its 6,7-dihydro biotransformation product
17. Isolation of mononuclear cells and granulocytes from human blood: Isolation of mononuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g
18. The kinetics of chemotactic peptide-induced change in F-actin content, F-actin distribution, and the shape of neutrophils
19. Eotaxin and RANTES enhance 5-oxo-6,8,11,14-eicosatetraenoic acid-induced eosinophil chemotaxis
20. 2 and histamine activate human eosinophils
21. 4 receptor
22. 5-Oxo-6,8,11,14-eicosatetraenoic acid is a potent stimulator of human eosinophil migration
23. 5-Oxo-eicosatetraenoate, a potent human neutrophil stimulus
24. 2 receptors in human platelets
25. Inducible cyclooxygenase may have anti-inflammatory properties
26. 2 inhibits IL-10 and IL-12 production by macrophages
27. Peroxisome proliferator-activated receptors (PPARs): Nuclear receptors at the crossroads between lipid metabolism and inflammation
28. Cyclopentenone prostaglandins: New insights on biological activities and cellular targets
29. PPARγ dependent and independent effects on macrophage-gene expression in lipid metabolism and inflammation
30. Genetic and pharmacological analysis of prostanoid receptor function
31. Novel antiinflammatory targets for asthma: A role for PPAR-γ?
32. 2: Identification of products formed in vitro
33. 2
34. 2, the peroxisome proliferator-activated receptor-γ ligand, in urine
35. 2 metabolite generated during inflammatory processes
36. 2 on malignant cells
37. 2 and its analogues
38. Synthesis and platelet aggregation inhibiting activity of prostaglandin D analogues
39. 2 exerting cell growth inhibition
40. 2 is an early anti-inflammatory signal in experimental colitis
41. 2 in the inhibition of epidermal Langerhans cell migration during schistosomiasis infection
42. 2 as a mediator of allergic asthma
43. 2 and the vascular changes of inflammation
44. 2 on allergen-induced airway responses and airway inflammation
45. 2: Apparent correlation with in vivo modulation of mediator release
46. Prostaglandins and leukotrienes: Advances in eicosanoid biology
47. Lipid mediator class switching during acute inflammation: Signals in resolution
48. Aspirin triggers previously undescribed bioactive eicosanoids by human endothelial cell-leukocyte interactions
49. 2